![Logo for PolyPeptide Group AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F19726-2023-05-12-02-45-14.png&w=256&q=100)
PolyPeptide Group Investor Relations Material
Latest events
![Logo for PolyPeptide Group AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F19726-2023-05-12-02-45-14.png&w=128&q=100)
H1 2024
PolyPeptide Group
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from PolyPeptide Group AG
Access all reports
PolyPeptide Group AG is a leading contract development and manufacturing organization (CDMO) specializing in the production of peptides and related molecules. The company provides services across the entire development spectrum, from initial peptide synthesis to commercial-scale manufacturing. PolyPeptide supports pharmaceutical and biotech companies with both proprietary and generic Good Manufacturing Practice (GMP)-grade peptides used in approved pharmaceutical products, drugs in clinical development, and in generic products. Additionally, it manufactures a variety of peptides used in cosmetic applications. The company is headquartered in Baar, Canton of Zug, Switzerland, and its shares are listed on the stock exchange.
Key slides for PolyPeptide Group AG
![We upgrade our guida](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fpolypeptide-group-ag-h1-2024-f7da85013b25f8e3%2F12.png&w=3840&q=75)
![Logo for PolyPeptide Group AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F19726-2023-05-12-02-45-14.png&w=128&q=100)
H1 2024
PolyPeptide Group AG
![Portfolio - Rapidly](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fpolypeptide-group-ag-h2-2023-b054f464120c12d6%2F11.png&w=3840&q=75)
![Logo for PolyPeptide Group AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F19726-2023-05-12-02-45-14.png&w=128&q=100)
H2 2023
PolyPeptide Group AG
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
PPGN
Country
🇨🇭 Switzerland